Leerink Partners has recently reduced CureVac BV (CVAC) stock to Market Perform rating, as announced on April 25, 2024, according to Finviz. Earlier, on June 8, 2023, SVB Securities had initiated the ...
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...
Shares of CureVac fell by 12.3% Wednesday afternoon. The pullback may stem from profit-taking after Tuesday's strong gains ...
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
Zacks.com on MSN2d
Vaccine Stocks Jump After CDC Reports First US Bird-Flu DeathOn Monday, the U.S. Centers for Disease Control and Prevention (“CDC”) reported the first human death in the country from the H5N1 virus, also known as bird flu. Despite the death, CDC believes that ...
Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...
Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...
Health-care companies rose as a reported U.S. death from bird flu stoked fears of a new pandemic, boosting shares of vaccine makers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback